·Î±×ÀÎ Àüü´º½º¿ÀÇǴϾðEnglishÆÊ ¾ÆÄ«µ¥¹ÌÆÊ½ºÅ¸Å¬·´TVÆÊµµ¶ó¸®Äí¸£Æ®DPºÎµ¿»êÀλ絿Á¤Event & Çмú¼¼¹Ì³ªµ¶ÀÚÁ¦º¸
°Ë»ö ä¿ëÁ¤º¸ °µ¿±¸¾à, ¸íÀϵ¿ ½ÌũȦ»ç°í ÇÇÇØ °¡Á· Áö¿ø ±â»çÀÔ·Â : 25.05.21 10:40:09 0 °¡ ÇÃÄ£Ãß°¡ [µ¥Àϸ®ÆÊ=°Çý°æ ±âÀÚ] ¼¿ï °µ¿±¸¾à»çȸ(ȸÀå ½Å¹Î°æ)°¡ Áö³ 3¿ù ¹ß»ýÇÑ ¸íÀϵ¿ ½ÌũȦ »ç°í ÇÇÇØ °¡Á·¿¡°Ô Áö¿ø±ÝÀ» Àü´ÞÇß´Ù. ±¸¾à»çȸ ¿©¾à»çÀ§¿øÈ¸(ºÎȸÀå ÃÖ¸íÈñ, À§¿øÀå ¾È¿µÈñ)´Â 19ÀÏ ¿ÀÀü 10½Ã °µ¿±¸Ã» º»°ü 3Ãþ º¹Áö°¡Á· ±¹Àå½Ç¿¡¼ Àü´Þ½ÄÀ» °¡Á³´Ù. ±¸¾à»çȸ´Â "¸íÀϵ¿¿¡¼ ¹ß»ýÇÑ ½ÌũȦ »ç°í·Î ÀÎÇØ ÇÇÇØ °¡Á·Àº ¹°·Ð ȸ¿øµé ¿ª½Ã Ãæ°ÝÀ» ¹Þ¾Ò´Ù"¸ç "¾à»çȸ¿øµéÀÇ Á¤¼ºÀÌ ÀÛ°Ô³ª¸¶ µµ¿òÀÌ µÆÀ¸¸é ÁÁ°Ú´Ù"°í ¸»Çß´Ù. À̳¯ Àü´Þ½Ä¿¡´Â ½Å¹Î°æ ȸÀå°ú ¹ÚÈñ¼º¡¤³ëÁøÈñ ¿©¾à»çÁöµµÀ§¿ø, À̼º¼ö °µ¿±¸Ã» º¹Áö°¡Á·±¹Àå, ½Å¼öÁ¤ º¹ÁöÁ¤Ã¥°úÀå, ±èÁÖ¿µ º¹ÁöÀÚ¿øÆÀÀåÀÌ Âü¼®Çß´Ù. X AD 2025 µÑÄÚ¶ô½º ½ÉÆ÷Áö¾ö REPLAY À̺¥Æ®Âü¿© ¡æ °Çý°æ ±âÀÚ(khk@dailypharm.com ) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¸ª°øÀå Á¦Á¶°ü¸®¾à»ç °æ·Â¹«°ü ¹Ù·Î°¡±â ¼¿ïƯº°½Ã Á¾·Î±¸ ÀÓ±âÁ¦°ø¹«¿ø(¾à»ç) ÀÓ¿ë°èȹ Àç°ø°í ¹Ù·Î°¡±â º»»ç ½ÅÀÔ RA ¾à»ç ä¿ë ¹Ù·Î°¡±â ¿ëÀÎ ¹é¾Ï°øÀå ǰÁú°ü¸® ¾à»ç ä¿ë(½ÅÀÔ/°æ·Â) ¹Ù·Î°¡±â º»»ç Medical Affairs ä¿ë(°ø°í¿¬Àå) ¹Ù·Î°¡±â MCE Strategy & Operations Specialist (»êÈÞ´ëü ÆÄ°ßÁ÷) ¹Ù·Î°¡±â Çâ³² °øÀå Á¦Á¶°ü¸®¾à»ç °æ·Âä¿ë ¹Ù·Î°¡±â Senior Associate, PV (Pharmacovigilance) ¹Ù·Î°¡±â [¾à»ç »ý»êº»ºÎÀå:°øÀåÀå]´ëÇüÄÚ½ºÇÇÁ¦¾à»ç(´ëÀü) ¹Ù·Î°¡±â [Çѵ¶] MA, Àü¹®ÀǾàǰ/ÀϹÝÀǾàǰ ¸¶ÄÉÆÃ, ÇØ¿Ü¿µ¾÷, CRA, ÀÇ·á±â±â Service Business, ¾à»ç, ±â¼úÆÀ ±³Á¤´ã´ç, Çѵ¶ÇコÄÉ¾î °æ¿µ°ü¸®,Ãѹ« ÆÀÀå ¹Ù·Î°¡±â °æ³² ÇԾȰøÀå ǰÁú°ü¸® ¾à»ç ä¿ë(½ÅÀÔ/°æ·Â) ¹Ù·Î°¡±â [Á¦¾à»ç¾÷ºÎ¹®] °³¹ßÆÀ(RA) ¾à»ç ½ÅÀÔ/°æ·Â ä¿ë ¹Ù·Î°¡±â Çѱ¹¿¡ÀÚÀÌ Market Access Leader ä¿ë ¹Ù·Î°¡±â Á¤±ÔÁ÷ ¾à¹«Á÷(ÆÀÀå) ¾à»ç ä¿ë °ø°í ¹Ù·Î°¡±â ÃæºÏ À½¼º Á¦Á¶°ü¸®¾à»ç °æ·Â¹«°ü ¹Ù·Î°¡±â RA Assistant Specialist (Contract) ½ÅÀÔ °¡´É ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æÄ§ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : °µ¿±¸¾à, ¸íÀϵ¿ ½ÌũȦ»ç°í ÇÇÇØ °¡Á· Áö¿ø URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ īī¿À½ºÅ丮 īī¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ °µ¿±¸¾à, ¸íÀϵ¿ ½ÌũȦ»ç°í ÇÇÇØ °¡Á· Áö¿ø ±â»çÀÔ·Â : 25.05.21 10:40:09 0 °¡ ÇÃÄ£Ãß°¡ [µ¥Àϸ®ÆÊ=°Çý°æ ±âÀÚ] ¼¿ï °µ¿±¸¾à»çȸ(ȸÀå ½Å¹Î°æ)°¡ Áö³ 3¿ù ¹ß»ýÇÑ ¸íÀϵ¿ ½ÌũȦ »ç°í ÇÇÇØ °¡Á·¿¡°Ô Áö¿ø±ÝÀ» Àü´ÞÇß´Ù. ±¸¾à»çȸ ¿©¾à»çÀ§¿øÈ¸(ºÎȸÀå ÃÖ¸íÈñ, À§¿øÀå ¾È¿µÈñ)´Â 19ÀÏ ¿ÀÀü 10½Ã °µ¿±¸Ã» º»°ü 3Ãþ º¹Áö°¡Á· ±¹Àå½Ç¿¡¼ Àü´Þ½ÄÀ» °¡Á³´Ù. ±¸¾à»çȸ´Â "¸íÀϵ¿¿¡¼ ¹ß»ýÇÑ ½ÌũȦ »ç°í·Î ÀÎÇØ ÇÇÇØ °¡Á·Àº ¹°·Ð ȸ¿øµé ¿ª½Ã Ãæ°ÝÀ» ¹Þ¾Ò´Ù"¸ç "¾à»çȸ¿øµéÀÇ Á¤¼ºÀÌ ÀÛ°Ô³ª¸¶ µµ¿òÀÌ µÆÀ¸¸é ÁÁ°Ú´Ù"°í ¸»Çß´Ù. À̳¯ Àü´Þ½Ä¿¡´Â ½Å¹Î°æ ȸÀå°ú ¹ÚÈñ¼º¡¤³ëÁøÈñ ¿©¾à»çÁöµµÀ§¿ø, À̼º¼ö °µ¿±¸Ã» º¹Áö°¡Á·±¹Àå, ½Å¼öÁ¤ º¹ÁöÁ¤Ã¥°úÀå, ±èÁÖ¿µ º¹ÁöÀÚ¿øÆÀÀåÀÌ Âü¼®Çß´Ù. X AD 2025 µÑÄÚ¶ô½º ½ÉÆ÷Áö¾ö REPLAY À̺¥Æ®Âü¿© ¡æ °Çý°æ ±âÀÚ(khk@dailypharm.com ) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¸ª°øÀå Á¦Á¶°ü¸®¾à»ç °æ·Â¹«°ü ¹Ù·Î°¡±â ¼¿ïƯº°½Ã Á¾·Î±¸ ÀÓ±âÁ¦°ø¹«¿ø(¾à»ç) ÀÓ¿ë°èȹ Àç°ø°í ¹Ù·Î°¡±â º»»ç ½ÅÀÔ RA ¾à»ç ä¿ë ¹Ù·Î°¡±â ¿ëÀÎ ¹é¾Ï°øÀå ǰÁú°ü¸® ¾à»ç ä¿ë(½ÅÀÔ/°æ·Â) ¹Ù·Î°¡±â º»»ç Medical Affairs ä¿ë(°ø°í¿¬Àå) ¹Ù·Î°¡±â MCE Strategy & Operations Specialist (»êÈÞ´ëü ÆÄ°ßÁ÷) ¹Ù·Î°¡±â Çâ³² °øÀå Á¦Á¶°ü¸®¾à»ç °æ·Âä¿ë ¹Ù·Î°¡±â Senior Associate, PV (Pharmacovigilance) ¹Ù·Î°¡±â [¾à»ç »ý»êº»ºÎÀå:°øÀåÀå]´ëÇüÄÚ½ºÇÇÁ¦¾à»ç(´ëÀü) ¹Ù·Î°¡±â [Çѵ¶] MA, Àü¹®ÀǾàǰ/ÀϹÝÀǾàǰ ¸¶ÄÉÆÃ, ÇØ¿Ü¿µ¾÷, CRA, ÀÇ·á±â±â Service Business, ¾à»ç, ±â¼úÆÀ ±³Á¤´ã´ç, Çѵ¶ÇコÄÉ¾î °æ¿µ°ü¸®,Ãѹ« ÆÀÀå ¹Ù·Î°¡±â °æ³² ÇԾȰøÀå ǰÁú°ü¸® ¾à»ç ä¿ë(½ÅÀÔ/°æ·Â) ¹Ù·Î°¡±â [Á¦¾à»ç¾÷ºÎ¹®] °³¹ßÆÀ(RA) ¾à»ç ½ÅÀÔ/°æ·Â ä¿ë ¹Ù·Î°¡±â Çѱ¹¿¡ÀÚÀÌ Market Access Leader ä¿ë ¹Ù·Î°¡±â Á¤±ÔÁ÷ ¾à¹«Á÷(ÆÀÀå) ¾à»ç ä¿ë °ø°í ¹Ù·Î°¡±â ÃæºÏ À½¼º Á¦Á¶°ü¸®¾à»ç °æ·Â¹«°ü ¹Ù·Î°¡±â RA Assistant Specialist (Contract) ½ÅÀÔ °¡´É ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æÄ§ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : °µ¿±¸¾à, ¸íÀϵ¿ ½ÌũȦ»ç°í ÇÇÇØ °¡Á· Áö¿ø URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ īī¿À½ºÅ丮 īī¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ °µ¿±¸¾à, ¸íÀϵ¿ ½ÌũȦ»ç°í ÇÇÇØ °¡Á· Áö¿ø ±â»çÀÔ·Â : 25.05.21 10:40:09 0 °¡ ÇÃÄ£Ãß°¡ [µ¥Àϸ®ÆÊ=°Çý°æ ±âÀÚ] ¼¿ï °µ¿±¸¾à»çȸ(ȸÀå ½Å¹Î°æ)°¡ Áö³ 3¿ù ¹ß»ýÇÑ ¸íÀϵ¿ ½ÌũȦ »ç°í ÇÇÇØ °¡Á·¿¡°Ô Áö¿ø±ÝÀ» Àü´ÞÇß´Ù. ±¸¾à»çȸ ¿©¾à»çÀ§¿øÈ¸(ºÎȸÀå ÃÖ¸íÈñ, À§¿øÀå ¾È¿µÈñ)´Â 19ÀÏ ¿ÀÀü 10½Ã °µ¿±¸Ã» º»°ü 3Ãþ º¹Áö°¡Á· ±¹Àå½Ç¿¡¼ Àü´Þ½ÄÀ» °¡Á³´Ù. ±¸¾à»çȸ´Â "¸íÀϵ¿¿¡¼ ¹ß»ýÇÑ ½ÌũȦ »ç°í·Î ÀÎÇØ ÇÇÇØ °¡Á·Àº ¹°·Ð ȸ¿øµé ¿ª½Ã Ãæ°ÝÀ» ¹Þ¾Ò´Ù"¸ç "¾à»çȸ¿øµéÀÇ Á¤¼ºÀÌ ÀÛ°Ô³ª¸¶ µµ¿òÀÌ µÆÀ¸¸é ÁÁ°Ú´Ù"°í ¸»Çß´Ù. À̳¯ Àü´Þ½Ä¿¡´Â ½Å¹Î°æ ȸÀå°ú ¹ÚÈñ¼º¡¤³ëÁøÈñ ¿©¾à»çÁöµµÀ§¿ø, À̼º¼ö °µ¿±¸Ã» º¹Áö°¡Á·±¹Àå, ½Å¼öÁ¤ º¹ÁöÁ¤Ã¥°úÀå, ±èÁÖ¿µ º¹ÁöÀÚ¿øÆÀÀåÀÌ Âü¼®Çß´Ù. X AD 2025 µÑÄÚ¶ô½º ½ÉÆ÷Áö¾ö REPLAY À̺¥Æ®Âü¿© ¡æ °Çý°æ ±âÀÚ(khk@dailypharm.com ) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç
0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æÄ§ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : °µ¿±¸¾à, ¸íÀϵ¿ ½ÌũȦ»ç°í ÇÇÇØ °¡Á· Áö¿ø URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ īī¿À½ºÅ丮 īī¿ÀÅå ¹êµå ³×À̹ö